| 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial … B Ibanez, S James, S Agewall, MJ Antunes, C Bucciarelli-Ducci, H Bueno, ... European heart journal 39 (2), 119-177, 2018 | 11774 | 2018 |
| 2018 ESC/EACTS Guidelines on myocardial revascularization FJ Neumann, M Sousa-Uva, A Ahlsson, F Alfonso, AP Banning, ... European heart journal 40 (2), 87-165, 2019 | 8146 | 2019 |
| Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents M Pfisterer, HP Brunner-La Rocca, PT Buser, P Rickenbacher, P Hunziker, ... Journal of the american College of Cardiology 48 (12), 2584-2591, 2006 | 1815 | 2006 |
| 2018 ESC/EACTS Guidelines on myocardial revascularization M Sousa-Uva, FJ Neumann, A Ahlsson, F Alfonso, AP Banning, ... European Journal of Cardio-Thoracic Surgery 55 (1), 4-90, 2019 | 677 | 2019 |
| Ten-year trends in the incidence and treatment of cardiogenic shock RV Jeger, D Radovanovic, PR Hunziker, ME Pfisterer, JC Stauffer, P Erne, ... Annals of internal medicine 149 (9), 618-626, 2008 | 502 | 2008 |
| Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011–2012 Pilot European Sentinel Registry G Nickenig, R Estevez-Loureiro, O Franzen, C Tamburino, ... Journal of the American College of Cardiology 64 (9), 875-884, 2014 | 416 | 2014 |
| Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial RV Jeger, A Farah, MA Ohlow, N Mangner, S Möbius-Winkler, ... The Lancet 392 (10150), 849-856, 2018 | 380 | 2018 |
| Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group RV Jeger, S Eccleshall, WA Wan Ahmad, J Ge, TC Poerner, ES Shin, ... Cardiovascular Interventions 13 (12), 1391-1402, 2020 | 343 | 2020 |
| Reduced leaflet motion after transcatheter aortic-valve replacement O De Backer, GD Dangas, H Jilaihawi, JA Leipsic, CJ Terkelsen, ... New England Journal of Medicine 382 (2), 130-139, 2020 | 259 | 2020 |
| Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization D Mylotte, RLJ Osnabrugge, S Windecker, T Lefèvre, P de Jaegere, ... Journal of the American College of Cardiology 62 (3), 210-219, 2013 | 252 | 2013 |
| Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group FX Kleber, H Rittger, K Bonaventura, U Zeymer, J Wöhrle, R Jeger, ... Clinical Research in Cardiology 102, 785-797, 2013 | 186 | 2013 |
| Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of … M Filipovic, R Jeger, C Probst, T Girard, M Pfisterer, L Gürke, K Skarvan, ... Journal of the American College of Cardiology 42 (10), 1767-1776, 2003 | 168 | 2003 |
| Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry D Sürder, G Pedrazzini, O Gaemperli, P Biaggi, C Felix, K Rufibach, ... Heart 99 (14), 1034-1040, 2013 | 162 | 2013 |
| Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials GG Stefanini, U Baber, S Windecker, MC Morice, S Sartori, MB Leon, ... The Lancet 382 (9908), 1879-1888, 2013 | 160 | 2013 |
| Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non … RV Jeger, A Farah, MA Ohlow, N Mangner, S Möbius-Winkler, ... The Lancet 396 (10261), 1504-1510, 2020 | 155 | 2020 |
| Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting MJ Zellweger, M Weinbacher, AW Zutter, RV Jeger, J Mueller-Brand, ... Journal of the American College of Cardiology 42 (1), 33-40, 2003 | 154 | 2003 |
| Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement: the randomized BRAVO-3 trial GD Dangas, T Lefèvre, C Kupatt, D Tchetche, U Schäfer, N Dumonteil, ... Journal of the American College of Cardiology 66 (25), 2860-2868, 2015 | 142 | 2015 |
| Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib ME Farkouh, JD Greenberg, RV Jeger, K Ramanathan, FWA Verheugt, ... Annals of the rheumatic diseases 66 (6), 764-770, 2007 | 141 | 2007 |
| Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry RV Jeger, SM Harkness, K Ramanathan, CE Buller, ME Pfisterer, ... European heart journal 27 (6), 664-670, 2006 | 132 | 2006 |
| Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome AW Schoenenberger, D Radovanovic, S Windecker, JF Iglesias, ... European heart journal 37 (16), 1304-1311, 2016 | 124 | 2016 |
